PRNP
Overview
PRNP (Prion Protein gene) is the chromosomal gene located on the short arm of chromosome 20 (20p13) in humans that encodes the prion protein, also known as PrP or cellular prion protein (PrPC). The PRNP gene is approximately 15 kilobases in length and contains two exons separated by an intron. This gene is fundamental to understanding prion diseases, a class of rapidly progressive, fatal neurodegenerative disorders that are unique in being both infectious and genetic. The protein product of PRNP exists in two conformational states: the normal cellular form (PrPC) and the pathogenic misfolded form (PrPSc), which is central to prion disease pathogenesis.
Function/Biology
The cellular prion protein (PrPC) is a glycoprotein constitutively expressed in neurons and other cell types, particularly abundant in the brain. PrPC is anchored to the cell membrane via a glycosylphosphatidylinositol (GPI) anchor and consists of approximately 253 amino acids in humans. The protein contains two N-linked glycosylation sites and a conserved disulfide bond, both of which are critical for its structure and function.
...PRNP
Overview
PRNP (Prion Protein gene) is the chromosomal gene located on the short arm of chromosome 20 (20p13) in humans that encodes the prion protein, also known as PrP or cellular prion protein (PrPC). The PRNP gene is approximately 15 kilobases in length and contains two exons separated by an intron. This gene is fundamental to understanding prion diseases, a class of rapidly progressive, fatal neurodegenerative disorders that are unique in being both infectious and genetic. The protein product of PRNP exists in two conformational states: the normal cellular form (PrPC) and the pathogenic misfolded form (PrPSc), which is central to prion disease pathogenesis.
Function/Biology
The cellular prion protein (PrPC) is a glycoprotein constitutively expressed in neurons and other cell types, particularly abundant in the brain. PrPC is anchored to the cell membrane via a glycosylphosphatidylinositol (GPI) anchor and consists of approximately 253 amino acids in humans. The protein contains two N-linked glycosylation sites and a conserved disulfide bond, both of which are critical for its structure and function.
While the precise physiological function of PrPC remains incompletely understood, evidence suggests multiple roles in normal neuronal homeostasis. PrPC appears involved in cell adhesion, signal transduction, and synaptic plasticity. The protein interacts with various ligands including laminin, heparan sulfate proteoglycans, and stress-inducible protein 1 (STI1). PrPC is internalized and recycled, with evidence suggesting roles in copper binding and antioxidant defense. The protein may also contribute to myelin maintenance and immune modulation.
Role in Neurodegeneration
PRNP mutations and conformational changes are the direct cause of prion diseases, a group of rapidly progressive, invariably fatal neurodegenerative conditions affecting humans and animals. Prion diseases are unique among neurodegenerative disorders in that they can be sporadic, inherited, or infectious. In all cases, the pathogenic mechanism involves conversion of PrPC into the misfolded PrPSc isoform.
In inherited prion diseases, mutations in the PRNP coding region predispose carriers to spontaneous misfolding and disease development. Over 50 pathogenic PRNP mutations have been identified, causing familial Creutzfeldt-Jakob disease (fCJD), familial fatal insomnia (FFI), and Gerstmann-Sträussler-Scheinker syndrome (GSS). These mutations increase the propensity for PrPC to undergo β-sheet-rich conformational change. The polymorphism at codon 129 (methionine/valine) significantly influences disease phenotype and progression rate in both inherited and sporadic forms.
Molecular Mechanisms
The pathogenic conversion of PrPC to PrPSc involves a dramatic conformational change: the normal protein contains approximately 42% α-helix and 3% β-sheet structure, while PrPSc is enriched in β-sheet content (approximately 43% β-sheet and reduced α-helix). This conformational transition occurs post-translationally and renders the protein protease-resistant, a hallmark of prion disease pathology.
The conversion mechanism appears to involve assisted folding, where existing PrPSc molecules template the misfolding of PrPC in a self-propagating cycle. This creates exponential accumulation of the pathogenic isoform. Cellular mechanisms including protein misfolding cyclic amplification (PMCA) and real-time quaking-induced conversion (RT-QuIC) can amplify minute quantities of PrPSc, enabling its detection in various biological samples.
Accumulation of PrPSc leads to neuronal dysfunction through multiple pathways, including excitotoxicity, oxidative stress, impaired protein quality control, synaptic dysfunction, and ultimately neuronal death, resulting in characteristic spongiform neuropathology.
Clinical/Research Significance
PRNP analysis is clinically essential for diagnosing inherited prion diseases and understanding disease susceptibility. Genetic testing identifies disease-causing mutations and risk-associated polymorphisms. PRNP genotyping informs prognosis prediction, as different codon 129 genotypes correlate with distinct clinical presentations and disease duration.
Research into PRNP-based therapeutics focuses on stabilizing PrPC structure, promoting PrPSc clearance, and blocking prion propagation. Understanding PRNP function offers insights into protein misfolding diseases broadly.
- Prion diseases (Creutzfeldt-Jakob disease, Kuru, scrapie)
- Prion protein conformers (PrPC, PrPSc)
- Protein misfolding cyclic amplification (PMCA)
- Neurodegenerative disease mechanisms
- Prion propagation and transmission